Compare, Analyse Abbott India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TEVA PHARMA (Israel) - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   TEVA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
TEVA PHARMA
Dec-13
ABBOTT INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8,8343,163-   
Low Rs5,4582,748-   
Sales per share (Unadj.) Rs1,731.11,815.6-  
Earnings per share (Unadj.) Rs211.9113.4-  
Cash flow per share (Unadj.) Rs219.9260.2-  
Dividends per share (Unadj.) Rs65.0099.28-  
Dividend yield (eoy) %0.93.4 27.1%  
Book value per share (Unadj.) Rs945.22,016.7-  
Shares outstanding (eoy) m21.25848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.6 253.5%   
Avg P/E ratio x33.726.1 129.4%  
P/CF ratio (eoy) x32.511.4 286.1%  
Price / Book Value ratio x7.61.5 515.8%  
Dividend payout %30.787.5 35.0%   
Avg Mkt Cap Rs m151,8482,506,527 6.1%   
No. of employees `0003.544.9 7.8%   
Total wages/salary Rs m4,3560-   
Avg. sales/employee Rs Th10,555.534,255.2 30.8%   
Avg. wages/employee Rs Th1,249.90-   
Avg. net profit/employee Rs Th1,292.22,139.9 60.4%   
INCOME DATA
Net Sales Rs m36,7861,539,598 2.4%  
Other income Rs m1,1330-   
Total revenues Rs m37,9191,539,598 2.5%   
Gross profit Rs m6,047421,620 1.4%  
Depreciation Rs m169124,447 0.1%   
Interest Rs m2330,240 0.1%   
Profit before tax Rs m6,989266,932 2.6%   
Minority Interest Rs m01,213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-175,226 0.0%   
Tax Rs m2,485-3,259 -76.3%   
Profit after tax Rs m4,50396,178 4.7%  
Gross profit margin %16.427.4 60.0%  
Effective tax rate %35.6-1.2 -2,912.7%   
Net profit margin %12.26.2 196.0%  
BALANCE SHEET DATA
Current assets Rs m27,6101,039,839 2.7%   
Current liabilities Rs m8,569906,827 0.9%   
Net working cap to sales %51.88.6 599.1%  
Current ratio x3.21.1 281.0%  
Inventory Days Days6091 66.3%  
Debtors Days Days2796 28.6%  
Net fixed assets Rs m1,057502,867 0.2%   
Share capital Rs m2133,790 5.6%   
"Free" reserves Rs m19,8730-   
Net worth Rs m20,0861,710,201 1.2%   
Long term debt Rs m0787,231 0.0%   
Total assets Rs m29,4093,518,475 0.8%  
Interest coverage x311.69.8 3,170.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.4 285.9%   
Return on assets %15.43.6 428.3%  
Return on equity %22.45.6 398.7%  
Return on capital %34.94.9 707.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-4,5490-   
CASH FLOW
From Operations Rs m4,991245,332 2.0%  
From Investments Rs m-2,570-86,931 3.0%  
From Financial Activity Rs m-1,428-294,293 0.5%  
Net Cashflow Rs m993-135,891 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.79 Rs / USD

Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ABBOTT INDIA With: GLENMARK PHARMA  FRESENIUS KABI ONCO.  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  PIRAMAL ENTERPRISES  



Today's Market

Indian Share Markets Recover Sharply; Sensex Up Over 500 Points(10:30 am)

Share markets in India quickly erased opening losses and gained sharply despite weakness in most global markets.

Related Views On News

TORRENT PHARMA at All Time High; BSE HEALTHCARE Index Up 3.1% (Market Updates)

Apr 8, 2020 | Updated on Apr 8, 2020

TORRENT PHARMA share price has hit an all time high at Rs 2,509 (up 2.9%). The BSE HEALTHCARE Index is up by 3.1%. Among the top gainers in the BSE HEALTHCARE Index today are TORRENT PHARMA (up 2.9%) and ABBOTT INDIA (up 3.7%). The top losers include GSK PHARMA (down 0.3%) and FORTIS HEALTHCARE (down 0.6%).

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 1.3% (Market Updates)

Apr 8, 2020 | Updated on Apr 8, 2020

ABBOTT INDIA share price has hit an all time high at Rs 16,999 (up 1.7%). The BSE HEALTHCARE Index is up by 1.3%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.7%) and SANOFI INDIA (up 1.3%). The top losers include ASTRAZENECA PHARMA and AJANTA PHARMA (down 0.1%).

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

How to Identify a Market Rebound (Fast Profits Daily)

Mar 27, 2020

This very useful indicator can spot a market bottom.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

ABBOTT INDIA SHARE PRICE


Apr 8, 2020 10:29 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

OTHER USEFUL LINKS

MARKET STATS